42
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 175-186 | Received 15 Jan 2024, Accepted 26 Feb 2024, Published online: 20 Mar 2024

References

  • Maruf AA , BousmanCA. Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. Psychiatry Clin. Neurosci. Rep.1(2), 1–11 (2022).
  • Bousman CA , MarufAA , MarquesDF , BrownLC , MüllerDJ. The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review. Psychol. Med.53(16), 1–11 (2023).
  • Memphis . Implementation. Clinical Pharmacogenetics Implementation Consortium. Tennessee, USA (2024). https://cpicpgx.org/implementation/
  • Haidar C-E , PetryN , OxencisC , DouglasJS , HoffmanJM. ASHP Statement on the pharmacist’s role in clinical pharmacogenomics. Am. J. Health Syst. Pharm.79(8), 704–707 (2022).
  • Maruf AA , AzizMA. The potential roles of pharmacists in the clinical implementation of pharmacogenomics. Pharmacy (Basel)11(6), 180 (2023).
  • Haga SB . The critical role of pharmacists in the clinical delivery of pharmacogenetics in the U.S. Pharmacy11(5), 144 (2023).
  • Hayashi M , HamdyDA , MahmoudSH. Applications for pharmacogenomics in pharmacy practice: a scoping review. Res. Social Adm. Pharm.18(7), 3094–3118 (2022).
  • Maruf AA , FanM , ArnoldPD , MüllerDJ , AitchisonKJ , BousmanCA. Pharmacogenetic testing options relevant to psychiatry in Canada. Can. J. Psychiatry65(8), 521–530 (2020).
  • Haga SB , KantorA. Horizon scan of clinical laboratories offering pharmacogenetic testing. Health Aff. (Millwood)37(5), 717–723 (2018).
  • Wondrasek A , FryzaA , AzizMA , LeongC , KowalecK , MarufAA. Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: a systematic review. Health Sci. Rep.7(1), e1844 (2024).
  • Hayashi M , BousmanCA. Experience, knowledge, and perceptions of pharmacogenomics among pharmacists and nurse practitioners in Alberta hospitals. Pharmacy10(6), 139 (2022).
  • de Denus S , LetarteN , HurlimannTet al. An evaluation of pharmacists’ expectations towards pharmacogenomics. Pharmacogenomics14(2), 165–175 (2013).
  • Meloche M , KwonHJ , LetarteNet al. Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists. Pharmacogenomics21(4), 235–245 (2020).
  • Petit C , CroisetièreA , ChenF , LaverdièreI. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice. Pharmacogenomics21(4), 247–256 (2020).
  • Canadian Pharmacists Association (CPhA) . Scope of Practice–English (2024). www.pharmacists.ca/advocacy/scope-of-practice/
  • Atkins L , FrancisJ , IslamRet al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement. Sci.12(1), 77 (2017).
  • Jessel CD , AlMaruf A , OomenA , ArnoldPD , BousmanCA. Pharmacogenetic testing knowledge and attitudes among pediatric psychiatrists and pediatricians in Alberta, Canada. J. Can. Acad. Child Adolesc. Psychiatry31(1), 18–27 (2022).
  • Harris PA , TaylorR , MinorBLet al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform.95, 103208 (2019).
  • Gammal RS , MayesJ , CaudleKE. Ready or not, here it comes: direct-to-consumer pharmacogenomic testing and its implications for community pharmacists. J. Am. Pharm. Assoc.59(5), 646–650 (2019).
  • Crown N , SprouleBA , LukeMJ , Piquette-MillerM , McCarthyLM. A continuing professional development program for pharmacists implementing pharmacogenomics into practice. Pharmacy (Basel)8(2), 55 (2020).
  • Luke MJ , KrupetskyN , LiuHet al. Pharmacists as personalized medicine experts (PRIME): experiences implementing pharmacist-led pharmacogenomic testing in primary care practices. Pharmacy (Basel)9(4), 201 (2021).
  • Breaux S , DesrosiersFAD , NeiraM , SinhaS , NislowC. Pharmacogenomics at the point of care: a community pharmacy project in British Columbia. J. Pers. Med.11(1), 11 (2020).
  • Hayashi M , MahmoudSH , HamdyDA. The efficacy of a didactic and case-based pharmacogenomics education program on improving the knowledge and confidence of Alberta pharmacists. Pharmgenomics Pers. Med.15, 409–427 (2022).
  • Pharmacogenomics for Community Pharmacists Online Version. Pharmacy Association of Nova Scotia. Dartmouth, NS (2024). https://pans.ns.ca/pharmacy-professionals/professional-development/online-courses/pharmacogenomics-community-1
  • Pharmacogenomics Knowledgebase (PharmGKB) . Educational resources for PharmGKB and PGxP (2024). www.pharmgkb.org/page/educationalResources
  • Alhaqan A , SmithF , BatesI. A global evidence review of systemic factors influencing participation in pharmacy professional development activities. Res. Soc. Adm. Pharm.17(3), 488–496 (2021).
  • Frigon M-P , BlackburnM-È , Dubois-BouchardC , GagnonA-L , TardifS , TremblayK. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics20(8), 589–598 (2019).
  • Morris SA , AlsaidiAT , VerbylaAet al. Cost effectiveness of pharmacogenetic testing for drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines: a systematic review. Clin. Pharmacol. Ther.112(6), 1318–1328 (2022).
  • Ghanbarian S , WongGWK , BunkaMet al. Cost-effectiveness of pharmacogenomic-guided treatment for major depression. CMAJ195(44), E1499–E1508 (2023).
  • Jennifer Paterson . Pharmacogenetic testing a growing area as pilot projects, research get underway (2018). www.benefitscanada.com/news/bencan/pharmacogenetics-testing-offering-opportunities-in-disability-drug-cost-management/
  • Resolute Legal Disability Lawyers . Long-term disability and pharmacogenomic testing (2022). www.resolutelegal.ca/long-term-disability-and-pharmacogenomic-testing/
  • Kastrinos A , Campbell-SalomeG , SheltonS , PetersonEB , BylundCL. PGx in psychiatry: patients’ knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing. Patient Educ. Couns.104(4), 732–738 (2021).
  • More patients, pharmacists adopting pharmacogenomics. BC Pharmacy Association (2019). www.bcpharmacy.ca/tablet/fall-19/more-patients-pharmacists-adopting-pharmacogenomics
  • Huston SA , ZdanowiczMM , FettermanJW. Pharmacogenomics in advanced pharmacy practice experiences. Curr. Pharm. Teach. Learn.2(4), 196–203 (2010).
  • Cohn I , CohnRD , ItoS. Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy. Can. Pharm. J. (Ott.)151(3), 167–169 (2018).
  • Kabbani D , AkikaR , WahidA , DalyAK , CascorbiI , ZgheibNK. Pharmacogenomics in practice: a review and implementation guide. Front. Pharmacol.14 (1189976), 1–23 (2023).
  • Reiss SM . American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J. Am. Pharm. Assoc.51(6), e64–e74 (2011).
  • 2022 Health Technology Trends to Watch. Canadian Agency for Drugs and Technologies in Health (2022). www.cadth.ca/2022-health-technology-trends-watch-0

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.